Our new lab is ready to collaborate!

5 November 2026

Our new laboratory is now operational, and we’re inviting collaborators in our trials to sending patient tumor samples for testing.
Our goal is unchanged to provide drug response profiling to navigate treatment decisions. With our activities now together under one roof at @Biopartner 2, @LeidenBioSciencePark, we’re ready to support the next phase of clinical validation and collaborative research.

What’s in place?
 Equipment relocated, calibrated and validated
 An ISO 15189-compliant Quality Management System
 Facilities equipped to work with genetically modified cells, including CAR-NK cells
 A team ready to coordinate sample logistics and testing with clinical partners

 Interested in contributing patient samples to our validation studies or exploring a research collaboration? Get in touch to discuss your patient population, sample requirements and study opportunities. We’ll help coordinate the next steps.

Together, we can build the evidence needed to bring predictive tumor testing closer to clinical practice.